Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Iressa vs Placebo as Maintenance Therapy in Locally Advanced NSCLC

This study has been terminated.
(Closed due to insufficient recruitment)
Sponsor:
Information provided by:
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00234468
First received: October 5, 2005
Last updated: May 19, 2011
Last verified: May 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2007
  Estimated Primary Completion Date: No date given